IMPORTANT UPDATE: On APRIL 28th, 2026, the Attorney General ordered the Rescheduling of Cannabis in the state medical cannabis programs from Schedule I to Schedule III through AG Order No. 6754-2026. Learn more about what this means for patients and caregivers here!
All other cannabis remains illegal and is classified as a Schedule I substance under the Controlled Substances Act
MEDICAL CANNABIS PATIENTS, HEALTHCARE AUTONOMY, & END-OF-LIFE CARE
Every year, millions of Americans require long-term or medium-term hospitalization, move into assisted living facilities, and enroll in hospice, where their medical choices are tightly regulated by institutional policy — and where medical cannabis use is often outright prohibited. Federal restrictions and outdated perceptions of cannabis prevent patients from exercising healthcare autonomy, especially in hospitals, hospices, and long-term care facilities.
THE SCOPE OF THE PROBLEM
Federal law still defines cannabis as a Schedule I substance with “no accepted medical use,” and many healthcare facilities — especially those receiving federal funding — prohibit its possession or use on site, regardless of state law. This impacts a staggering number of patients:
2.2 million people currently live in long-term care settings in the U.S.
1.72 million Americans enroll in hospice care every year.
36 million people have inpatient hospital stays annually — and for some, these are prolonged, with a median length of 26 days for extended hospitalizations.
WHEN ACCESS TO MEDICINE DELAYS CARE
Because hospitalizations often require discontinuing cannabis, many medical cannabis patients delay or avoid surgeries, procedures, or emergency room visits for fear of losing access to their primary therapy. This hesitation can worsen health outcomes and lead to medical crises that might otherwise have been prevented.
The problem extends into end-of-life care: many patients want to use cannabis instead of heavy opioids like morphine during their final days so they can remain alert, present, and able to say goodbye to loved ones. Current institutional bans deny them that choice.
Patient Story: Eleanor, Hospice Patient
Eleanor, 69, was diagnosed with late-stage pancreatic cancer. She used medical cannabis to manage pain and nausea, allowing her to enjoy visits with her grandchildren. When she entered hospice, the facility prohibited cannabis, offering only morphine. Eleanor reluctantly agreed, but the sedation left her unable to hold meaningful conversations during her final days. Her family says she was “gone” long before she passed — not because of her illness, but because of policy.
CANNABIS BANS IN CARE SETTINGS
Hospitals, hospices, and assisted living facilities often cite two main reasons for banning cannabis:
- Federal Funding Compliance — Facilities worry that permitting cannabis use could jeopardize Medicare, Medicaid, or VA funding.
- Legal Liability — Administrators fear federal enforcement actions or state/federal regulatory conflicts.
The result? Patients who arrive at a facility using cannabis under a state medical program may be forced to discontinue a physician-guided treatment — leading to unnecessary suffering, loss of symptom control, and diminished quality of life during what may be their final days.
Patient Story: David, Post-Surgery Recovery
David, 55, underwent spinal surgery after years of debilitating pain. Before his operation, he relied on cannabis to reduce muscle spasms and avoid opioids. Post-surgery, during his rehabilitation in a hospital, he was told cannabis was not allowed. His spasms worsened, recovery slowed, and he was placed on high-dose opioids that left him groggy and dependent — a setback that could have been avoided if his treatment plan had been respected.
AUTONOMY & END-OF-LIFE CHOICE
Healthcare autonomy is a cornerstone of modern medical ethics. Patients have the right to refuse treatment, choose comfort-focused care, and, in some states, pursue medical aid in dying. Yet for medical cannabis patients, autonomy stops at the facility door.
This creates a cruel contradiction: patients can legally choose to refuse treatments and hasten death, but cannot choose to use cannabis to ease their suffering while they are still alive.
Patient Story: Marisol, Assisted Living Resident
Marisol, 78, lives in an assisted living facility after a stroke left her with chronic neuropathic pain. Cannabis provided her the only consistent relief without severe side effects. When management discovered her state-issued medical cannabis, she was told she could either stop using it or leave. With no family nearby and few options, Marisol gave up her medicine, and her pain returned full force.
WHY ONLY FEDERAL LEGISLATION CAN FIX THIS
The root problem is federal prohibition of medical cannabis that shapes these healthcare policies; no patchwork of state laws will fully protect patient rights in institutional care. The Medical Cannabis and Cannabinoid Act (MCCA) is designed to address this gap by:
- Recognizing medical cannabis under federal law
- Protecting facilities from federal penalties
- Ensuring patient autonomy in long-term care, hospice, and hospital settings so that access to cannabis therapy is preserved during critical and end-of-life care.
For millions of Americans in hospitals, hospices, and long-term care, medical cannabis bans rob them of comfort, dignity, and control over their own medical decisions. Patients like Eleanor, David, and Marisol show that these policies cause real harm — silencing final goodbyes, slowing recovery, and stripping away relief in the last chapters of life.
The MCCA offers a clear, compassionate fix: it would protect patient rights, shield facilities from federal retaliation, and ensure that no one has to spend their last days in unnecessary pain or sedation because of outdated policies.
It’s time to align federal law with both medical reality and human dignity. It’s time to pass the MCCA.
If you appreciate ASA's work, sign up to get alerts and updates and make a donation to support ASA's vital mission.
Share this page
